US Patent Issued to Merck Sharp & Dohme on Feb. 3 for "N-(heteroaryl) quinazolin-2-amine derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof" (Massachusetts, New Jersey, California Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,131, issued on Feb. 3, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).

"N-(heteroaryl) quinazolin-2-amine derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof" was invented by Mitchell H. Keylor (Malden, Mass.), Michael J. Ardolino (Arlington, Mass.), Ryan W. Chau (Somerville, Mass.), Peter H. Fuller (Ashland, Mass.), Anmol Gulati (Watertown, Mass.), Rebecca Elizabeth Johnson (Oakland, Calif.), Solomon D. Kattar (Wakefield, Mass.), Kaila A. Margrey (Cambridge, Mass.), Gregori J. Morriello (Randolph, N.J.), Santhosh F. Neelamkavil (Edison, N.J.), Xin Yan (Newton, Mass.), Elsie C. Yu (Brighton, Mass.) and Cayetana Carmela Zarate Saez (Boston).

Accor...